Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease

Prahlad K. Rao, Kate Merath, Eugene Drigalenko, Avinash Y.L. Jadhav, Richard A. Komorowski, Matthew I. Goldblatt, Anand Rohatgi, Mark A. Sarzynski, Samer Gawrieh, Michael Olivier

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Metabolic diseases such as obesity and diabetes are associated with changes in high-density lipoprotein (HDL) particles, including changes in particle size and protein composition, often resulting in abnormal function. Recent studies suggested that patients with non-alcoholic fatty liver disease (NAFLD), including individuals with non-alcoholic steatohepatitis (NASH), have smaller HDL particles when compared to individuals without liver pathologies. However, no studies have investigated potential changes in HDL particle protein composition in patients with NAFLD, in addition to changes related to obesity, to explore putative functional changes of HDL which may increase the risk of cardiovascular complications. Methods: From a cohort of morbidly obese females who were diagnosed with simple steatosis (SS), NASH, or normal liver histology, we selected five matched individuals from each condition for a preliminary pilot HDL proteome analysis. HDL particles were enriched using size-exclusion chromatography, and the proteome of the resulting fraction was analyzed by liquid chromatography tandem mass spectrometry. Differences in the proteomes between the three conditions (normal, SS, NASH) were assessed using label-free quantitative analysis. Gene ontology term analysis was performed to assess the potential impact of proteomic changes on specific functions of HDL particles. Results: Of the 95 proteins identified, 12 proteins showed nominally significant differences between the three conditions. Gene ontology term analysis revealed that severity of the liver pathology may significantly impact the anti-thrombotic functions of HDL particles, as suggested by changes in the abundance of HDL-associated proteins such as antithrombin III and plasminogen. Conclusions: The pilot data from this study suggest that changes in the HDL proteome may impact the functionality of HDL particles in NAFLD and NASH patients. These proteome changes may alter cardio-protective properties of HDL, potentially contributing to the increased cardiovascular disease risk in affected individuals. Further validation of these protein changes by orthogonal approaches is key to confirming the role of alterations in the HDL proteome in NAFLD and NASH. This will help elucidate the mechanistic effects of the altered HDL proteome on cardioprotective properties of HDL particles.

Original languageEnglish (US)
Article number10
JournalClinical Proteomics
Volume15
Issue number1
DOIs
StatePublished - Mar 6 2018

Fingerprint

HDL Lipoproteins
Liver
Proteomics
Proteome
Fatty Liver
Gene Ontology
Proteins
Non-alcoholic Fatty Liver Disease
Pathology
Ontology
Obesity
Genes
Chemical analysis
Histology
Antithrombin III
Size exclusion chromatography
Plasminogen
Metabolic Diseases
Liquid chromatography
Medical problems

Keywords

  • Anti-thrombotic
  • High-density lipoproteins
  • Non-alcoholic fatty liver disease
  • Obesity
  • Proteomics

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Rao, P. K., Merath, K., Drigalenko, E., Jadhav, A. Y. L., Komorowski, R. A., Goldblatt, M. I., ... Olivier, M. (2018). Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease. Clinical Proteomics, 15(1), [10]. https://doi.org/10.1186/s12014-018-9186-0

Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease. / Rao, Prahlad K.; Merath, Kate; Drigalenko, Eugene; Jadhav, Avinash Y.L.; Komorowski, Richard A.; Goldblatt, Matthew I.; Rohatgi, Anand; Sarzynski, Mark A.; Gawrieh, Samer; Olivier, Michael.

In: Clinical Proteomics, Vol. 15, No. 1, 10, 06.03.2018.

Research output: Contribution to journalArticle

Rao, PK, Merath, K, Drigalenko, E, Jadhav, AYL, Komorowski, RA, Goldblatt, MI, Rohatgi, A, Sarzynski, MA, Gawrieh, S & Olivier, M 2018, 'Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease', Clinical Proteomics, vol. 15, no. 1, 10. https://doi.org/10.1186/s12014-018-9186-0
Rao, Prahlad K. ; Merath, Kate ; Drigalenko, Eugene ; Jadhav, Avinash Y.L. ; Komorowski, Richard A. ; Goldblatt, Matthew I. ; Rohatgi, Anand ; Sarzynski, Mark A. ; Gawrieh, Samer ; Olivier, Michael. / Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease. In: Clinical Proteomics. 2018 ; Vol. 15, No. 1.
@article{9fcdb1e2776a4301be1eb266d4dc25f3,
title = "Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease",
abstract = "Background: Metabolic diseases such as obesity and diabetes are associated with changes in high-density lipoprotein (HDL) particles, including changes in particle size and protein composition, often resulting in abnormal function. Recent studies suggested that patients with non-alcoholic fatty liver disease (NAFLD), including individuals with non-alcoholic steatohepatitis (NASH), have smaller HDL particles when compared to individuals without liver pathologies. However, no studies have investigated potential changes in HDL particle protein composition in patients with NAFLD, in addition to changes related to obesity, to explore putative functional changes of HDL which may increase the risk of cardiovascular complications. Methods: From a cohort of morbidly obese females who were diagnosed with simple steatosis (SS), NASH, or normal liver histology, we selected five matched individuals from each condition for a preliminary pilot HDL proteome analysis. HDL particles were enriched using size-exclusion chromatography, and the proteome of the resulting fraction was analyzed by liquid chromatography tandem mass spectrometry. Differences in the proteomes between the three conditions (normal, SS, NASH) were assessed using label-free quantitative analysis. Gene ontology term analysis was performed to assess the potential impact of proteomic changes on specific functions of HDL particles. Results: Of the 95 proteins identified, 12 proteins showed nominally significant differences between the three conditions. Gene ontology term analysis revealed that severity of the liver pathology may significantly impact the anti-thrombotic functions of HDL particles, as suggested by changes in the abundance of HDL-associated proteins such as antithrombin III and plasminogen. Conclusions: The pilot data from this study suggest that changes in the HDL proteome may impact the functionality of HDL particles in NAFLD and NASH patients. These proteome changes may alter cardio-protective properties of HDL, potentially contributing to the increased cardiovascular disease risk in affected individuals. Further validation of these protein changes by orthogonal approaches is key to confirming the role of alterations in the HDL proteome in NAFLD and NASH. This will help elucidate the mechanistic effects of the altered HDL proteome on cardioprotective properties of HDL particles.",
keywords = "Anti-thrombotic, High-density lipoproteins, Non-alcoholic fatty liver disease, Obesity, Proteomics",
author = "Rao, {Prahlad K.} and Kate Merath and Eugene Drigalenko and Jadhav, {Avinash Y.L.} and Komorowski, {Richard A.} and Goldblatt, {Matthew I.} and Anand Rohatgi and Sarzynski, {Mark A.} and Samer Gawrieh and Michael Olivier",
year = "2018",
month = "3",
day = "6",
doi = "10.1186/s12014-018-9186-0",
language = "English (US)",
volume = "15",
journal = "Clinical Proteomics",
issn = "1542-6416",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease

AU - Rao, Prahlad K.

AU - Merath, Kate

AU - Drigalenko, Eugene

AU - Jadhav, Avinash Y.L.

AU - Komorowski, Richard A.

AU - Goldblatt, Matthew I.

AU - Rohatgi, Anand

AU - Sarzynski, Mark A.

AU - Gawrieh, Samer

AU - Olivier, Michael

PY - 2018/3/6

Y1 - 2018/3/6

N2 - Background: Metabolic diseases such as obesity and diabetes are associated with changes in high-density lipoprotein (HDL) particles, including changes in particle size and protein composition, often resulting in abnormal function. Recent studies suggested that patients with non-alcoholic fatty liver disease (NAFLD), including individuals with non-alcoholic steatohepatitis (NASH), have smaller HDL particles when compared to individuals without liver pathologies. However, no studies have investigated potential changes in HDL particle protein composition in patients with NAFLD, in addition to changes related to obesity, to explore putative functional changes of HDL which may increase the risk of cardiovascular complications. Methods: From a cohort of morbidly obese females who were diagnosed with simple steatosis (SS), NASH, or normal liver histology, we selected five matched individuals from each condition for a preliminary pilot HDL proteome analysis. HDL particles were enriched using size-exclusion chromatography, and the proteome of the resulting fraction was analyzed by liquid chromatography tandem mass spectrometry. Differences in the proteomes between the three conditions (normal, SS, NASH) were assessed using label-free quantitative analysis. Gene ontology term analysis was performed to assess the potential impact of proteomic changes on specific functions of HDL particles. Results: Of the 95 proteins identified, 12 proteins showed nominally significant differences between the three conditions. Gene ontology term analysis revealed that severity of the liver pathology may significantly impact the anti-thrombotic functions of HDL particles, as suggested by changes in the abundance of HDL-associated proteins such as antithrombin III and plasminogen. Conclusions: The pilot data from this study suggest that changes in the HDL proteome may impact the functionality of HDL particles in NAFLD and NASH patients. These proteome changes may alter cardio-protective properties of HDL, potentially contributing to the increased cardiovascular disease risk in affected individuals. Further validation of these protein changes by orthogonal approaches is key to confirming the role of alterations in the HDL proteome in NAFLD and NASH. This will help elucidate the mechanistic effects of the altered HDL proteome on cardioprotective properties of HDL particles.

AB - Background: Metabolic diseases such as obesity and diabetes are associated with changes in high-density lipoprotein (HDL) particles, including changes in particle size and protein composition, often resulting in abnormal function. Recent studies suggested that patients with non-alcoholic fatty liver disease (NAFLD), including individuals with non-alcoholic steatohepatitis (NASH), have smaller HDL particles when compared to individuals without liver pathologies. However, no studies have investigated potential changes in HDL particle protein composition in patients with NAFLD, in addition to changes related to obesity, to explore putative functional changes of HDL which may increase the risk of cardiovascular complications. Methods: From a cohort of morbidly obese females who were diagnosed with simple steatosis (SS), NASH, or normal liver histology, we selected five matched individuals from each condition for a preliminary pilot HDL proteome analysis. HDL particles were enriched using size-exclusion chromatography, and the proteome of the resulting fraction was analyzed by liquid chromatography tandem mass spectrometry. Differences in the proteomes between the three conditions (normal, SS, NASH) were assessed using label-free quantitative analysis. Gene ontology term analysis was performed to assess the potential impact of proteomic changes on specific functions of HDL particles. Results: Of the 95 proteins identified, 12 proteins showed nominally significant differences between the three conditions. Gene ontology term analysis revealed that severity of the liver pathology may significantly impact the anti-thrombotic functions of HDL particles, as suggested by changes in the abundance of HDL-associated proteins such as antithrombin III and plasminogen. Conclusions: The pilot data from this study suggest that changes in the HDL proteome may impact the functionality of HDL particles in NAFLD and NASH patients. These proteome changes may alter cardio-protective properties of HDL, potentially contributing to the increased cardiovascular disease risk in affected individuals. Further validation of these protein changes by orthogonal approaches is key to confirming the role of alterations in the HDL proteome in NAFLD and NASH. This will help elucidate the mechanistic effects of the altered HDL proteome on cardioprotective properties of HDL particles.

KW - Anti-thrombotic

KW - High-density lipoproteins

KW - Non-alcoholic fatty liver disease

KW - Obesity

KW - Proteomics

UR - http://www.scopus.com/inward/record.url?scp=85043289679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043289679&partnerID=8YFLogxK

U2 - 10.1186/s12014-018-9186-0

DO - 10.1186/s12014-018-9186-0

M3 - Article

VL - 15

JO - Clinical Proteomics

JF - Clinical Proteomics

SN - 1542-6416

IS - 1

M1 - 10

ER -